There are always updates on the card such as for the ongoing NK-trial, the upcoming CDH 17 ph1 start and of course the highly anticipated CLTX CAR-T Brain cancer ph 1 read out by end of this year. But I agree that in the current market climate only news that suggest a deal opportunity will drive the sp up.
Would rather have seen Bell Potter driving the sp to 10c and then a raise but we now got 4c and have to adjust to that level. If they get outstanding data then the MC will easily go above $ 100m, that would be about 15c -20c or so assuming 600 - 750m shares fully diluted, depending on whether the CHMO will have a chance to be converted. Anything is possible but at this stage I consider them to be lost.
Time will tell.
GLTA
Ann: BOARD & MANAGEMENT COMMIT TO $1M PLACEMENT AND PROPOSED SPP, page-17
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.776M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.0¢ | 0.9¢ | $9.73K | 1.077M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 5624045 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 3249484 | 8 |
View Market Depth
| Last trade - 14.35pm 01/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |